Not only did the NYT omit several large, reliable studies on antidepressant use during pregnancy and fail to include views from experts in the field of reproductive mental health, but the tone of the article is demeaning to women facing the difficult choice of taking medication to treat mental illness during pregnancy.
Only those who have a personal experience with depression can understand the scope of pain from this form of mental illness. It is a debilitating disease that robs a person of the simplest joys in life. It carves a hole too deep to fill in the hearts of those who wrestle with the inner demons of this acute, medical condition.
Healthcare professionals must balance the possible risks of a medication against the possible benefit. In a pregnant woman, that requires considering the effect of an untreated mood or psychiatric disorder on a fetus or developing child against the risk of medication-related birth defects or other problems after a child is born.
Last week I went to a presentation by Robert Whitaker, author of Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America. Having spent a lot of time in the pharmaceutical trenches, I think my perspective on psychiatric meds is a little different from his, but there were two things in particular that impressed me.
Nighttime creepy-crawlies aren't limited to camping or Halloween. For approximately 10 percent of Americans, tingly, itchy sensations -- mostly between the ankle and the knee -- aren't the creeping of spiders or the fluttering of bats, but a neurological disorder called Restless Legs Syndrome, or RLS.